Keryx Biopharmaceuticals Inc
KERX
KERX was delisted on the 12th of December, 2018.
150 hedge funds and large institutions have $1.14B invested in Keryx Biopharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 15 closing their positions.
173% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 15
73% more capital invested
Capital invested by funds: $660M → $1.14B (+$484M)
21% more funds holding
Funds holding: 124 → 150 (+26)
18% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 44
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
12% more call options, than puts
Call options by funds: $32.6M | Put options by funds: $29.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
+$95.2M |
| 2 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
+$31.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25M |
| 4 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$23M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$20.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$22M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13.1M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$12M |
| 4 |
D.E. Shaw & Co
New York
|
-$9.69M |
| 5 |
Goldman Sachs
New York
|
-$7.76M |
KERX Hedge Fund Activity: Q1 2014 in Review
150 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q1 2014, worth a combined $1.14B — up 73% from $660M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new KERX positions and 15 closed out — a net gain of 26 holders — while 52 added to existing stakes and 44 trimmed.
The largest buyer was Baupost Group, opening a new position worth an estimated $95.2M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $22M sold.
- 150 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q1 2014, up from 124 in Q4 2013.
- Funds reported $1.14B of Keryx Biopharmaceuticals Inc stock for Q1 2014, up 73% quarter-over-quarter.
- 41 funds opened new Keryx Biopharmaceuticals Inc positions in Q1 2014 and 15 closed out, a net change of +26 holders.
- The largest Keryx Biopharmaceuticals Inc buyer in Q1 2014 was Baupost Group, an estimated $95.2M added.
- The largest Keryx Biopharmaceuticals Inc seller in Q1 2014 was Cormorant Asset Management, an estimated $22M sold.
Based on aggregated 13F filings for Q1 2014.